
Rx91 Global LLP
About Rx91 Global LLP
Data last updated:
Rx91 Global LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 24 August 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAY-3163. Its GSTIN is 07ABSFM5329D1Z2 (Delhi).
The LLP has a total obligation of contribution of βΉ1 Lakh. It was formerly known as Metallurgy Research Llp. It is led by designated partners Kriti Goel and Manish Goel.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No 1062 Sector G Block G Dsidc Narela, Delhi, India β 110040.
Court records list 3 cases involving the LLP, including 3 filed against it; 3 cases are pending.
Company details
Contact details
Rx91 Global LLP's registered office is in Delhi, Delhi.
- Registered AddressPlot No 1062 Sector G Block G Dsidc Narela, Delhi, India β 110040
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rx91 Global LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Rx91 Global LLP, buy the company report.
Designated partners of Rx91 Global LLP
Rx91 Global has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kriti Goel Also directs: Ark Research LLP, Rx91 Web Private Limited | Designated Partner | 24 Aug 2021 | 5 Years 2 Months | Current |
| Manish Goel | Designated Partner | 24 Aug 2021 | 5 Years 2 Months | Current |
Legal cases
Rx91 Global LLP has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Shalina Laboratories Private Limited and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Shalina Laboratories Pvt Ltd | Pending |
| High Court | Court case (COMIP) | Filed against the company by Shalina Laboratories Pvt Ltd and 1 other | Pending |
To see the full case history of Rx91 Global LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rx91 Global LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rx91 Global has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABSFM5329D1Z2 | Delhi | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Rx91 Global LLP, buy the company report.
Recent activity
Rx91 Global LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Kriti Goel was appointed as Designated Partner on 24 Aug 2021.
Frequently asked questions
Rx91 Global is an active limited liability partnership based in Delhi, India. The LLP works in preventive health services, within the healthcare industry. It was incorporated on 24 August 2021 (5+ years old) and is registered under LLPIN AAY-3163.
Rx91 Global has 2 current designated partners:
- Kriti Goel - Designated Partner
- Manish Goel - Designated Partner
The latest financial statements of Rx91 Global on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Rx91 Global is 07ABSFM5329D1Z2, registered in Delhi.
The LLPIN (Limited Liability Partnership Identification Number) of Rx91 Global is AAY-3163. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Rx91 Global has 3 court cases on record: 3 filed against it. 3 are pending.
Rx91 Global was incorporated on 24 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Kriti Goel was appointed as Designated Partner on 24 Aug 2021. Manish Goel was appointed as Designated Partner on 24 Aug 2021.
The registered office of Rx91 Global is at Plot No 1062 Sector G Block G Dsidc Narela, Delhi, India β 110040.
Rx91 Global operates in the healthcare industry, in the preventive health services segment.